LUGPA 2022 VL

Penile Prosthesis - Optimizing Ambulatory Surgery Center Utilization Penile-Implant- Post Prostatectomy LUGPA 2022 Presentation - Sherita King

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Sherita King presented on penile implant-post prostatectomy during optimizing ambulatory surgery centers (ASC) utilization. Biography: Sherita A. King, MD, Director of Prosthetics and Sexual Medicine, Assistant Professor, Medical College of Georgia, Augusta University, Augusta, GA Related Content: New Findings Regarding t...

mCSPC Couplet vs Triplet Therapy LUGPA 2022 Presentation - Alicia Morgans

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Alicia Morgans presented on couplet versus triplet therapy for metastatic castrate-sensitive prostate cancer (mCSPC). Biography: Alicia Morgans, MD, MPH , Genitourinary Medical Oncologist, Medical Director of Survivorship Program at Dana-Farber Cancer Institute, Boston, Massachusetts Related Content: APCCC 2022: Treatment...

Diversity in Urology - Care for Transgender and Gender Diverse Patients LUGPA 2022 Presentation - Diana Bowen

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Diana Bowen presents on diversity in urology: care for transgender and gender diverse patients. Biography: Diana K. Bowen, MD, Assistant Professor of Urology, Co-Director of Gender Pathways Program, Northwestern Medicine, Chicago, IL Read the Full Video Transcript

Diana Bowen: Hi, my name's Diana Bowen, and thank you for having me. I have no disclosures.

So my talk is really expanding on the last two talks, to try to give you some practical tips on how to make any gender diverse patient coming to your clinic have a great affirming equitable experience. And so, I kind of broke it down into just the general clinic experience, and then some specifics with urologic concerns outside of bottom surgery.

So why am I talking about this? Well, like Dr. Figler, we created at Northwestern, a program that's comprehensive about four years ago, surgeon led, but we understood very quickly, we needed to touch all aspects of care. And so, I'm drawing from some of these lived experiences with patients and our health system, to hopefully give you some knowledge about that.

I think that, just like the explosion of bottom surgery, there's an explosion of transgender legislation. But it really doesn't matter whether you're in a state that has gender expansive legislation, or gender restrictive legislation going on, there's increasing acceptance nationally, culturally. And so, you will be seeing gender patients, and they deserve to get great urologic care.

I won't belabor this because Dr. Figler went through this, but it has to be in the scope of the fact that, most of these patients have had either a negative healthcare experience. They don't want to see a doctor because they're afraid, or they have to report teaching their doctor about their own care.

When I think about the clinic experience, I kind of broke it down into three different domains. There's the overall physical environment, there's the workforce, and then there's patient information.

And so, the physical environment matters. Patients coming into your office, seeing perhaps, an all gender restroom for a single stall, that's important. Seeing a waiting space that may have magazines or posters that are not just cis heteronormative. And potentially, even going as far as to have safe space signage, which we developed at Northwestern, and offered to all the different departments, as an opt-in to put in their waiting room.

For workforce, I'll get into this in a little bit, but terminology and pronouns are really important, and not just for you, right? A patient may see three, four other people before they get to you. And so, educating your work staff about these issues is important, through cultural competency trainings. And then, how do you get this information through intake sheets, and through the EMR?

Before I get into those, things to keep in mind, I think it's important that affirming care goes just beyond your gender diverse patients. You most likely have staff that are gender diverse, they may not be out to you, and the same goes for patients not being out to you as well. So I think that putting some of this language into daily use is a really good idea.

We put together some cultural competency trainings when we started this program for the whole institution, Northwestern. It was a big undertaking, but we focused on terminology because we found that people were really hungry for terminology, and ways to use language. Right? And that was the feedback we got. They just want resources.

And so, we provide these resources, and I'm happy to provide any of these for you. Things like staff tip sheets, where you give them the language to say, "Hi, my name is so and so. I use these pronouns." Everybody's scared about what people will say back to them. Right? And so, giving them language to address those concerns, like this is a question we ask everyone because, and so on. I think those are always helpful.

You can modify your intake forms that can be additive. It doesn't need to change dramatically, but putting in things like a preferred name and optional pronouns, as well as after legal sex, gender identity, also optional.

The EMR is a bear, but it can also be a tool, like in most things. And so, there's actually good studies showing most TGD patients would like their preferred name and pronoun documentation to be part of it. You can contact your EMR provider for the latest updates in the SOGI data. And I'll touch on organ inventory.

So is, we use EPIC. This is obviously a fake patient, but you can see here in that top left, you have the patient's legal name, and then in quotations you have their preferred name, and then female with an I, showing that it doesn't match up with their legal sex.

The patient can put that in through MyChart, or you can do it in your encounter. And that lets everybody, again, PSRs, the MAs, the nurses, know how to address the patient. And right here is an example of all the different options they have to choose from, and they can also put in their pronouns.

And I think in the future, organ inventories are going to be really important, as patients start to come in and not just identify as transgender or female. They want to s=ay, "I'm female, well, but I have a prostate." And so, that's important for cancer screenings going forward.

So lastly, we'll talk about urologic care. So again, outside of bottom surgery, any urologic complaint, right? Patients will come in with stones, phimosis, hydrocele. And so, it's important to collect a detailed information history, about their bottom surgery history, or any gender affirming interventions, especially hormones. But you can't assume that they've had these things. The majority of patients have not had bottom surgery.

Genital exams are very, very anxiety producing, provoking for patients. And so, I find that letting the patient know at the beginning of the encounter, "Hey, we're going to do an exam later on. This is why we're going to do an exam. Are you okay with that?" Let’s them process it a little bit, and tell you about any bad experience they've had. And I think that spending the extra time to do that is really important for these patients. Because many have had negative experiences in healthcare.

I see a lot of patients with lower urinary tract dysfunction. When you start a program, people start coming to you. And so, I think that it's multifactorial. A lot of patients avoid public restrooms, so they hold their urine. There's common coexisting mental health disorders. Hormones can trigger or compound existing problems. And so, I think being aware of all of those different factors, in addition to what you would normally do with any patient who came in with this problem, it's important.

Also important to know that a lot of trans women will do something called tucking, where they push the testicles up into the inguinal canal. And so, you could see maybe, things like testicular pain, orchitis UTIs, and you just have to kind of think about it a little bit differently and know that that exists. There's no real literature though, to go off of.

Cancer screening. So there's no WPATH. WPATH, Dr. Figler referenced. There's no guidelines specific to prostate cancer screening. You would think that it would be much lower with the hormones that patients are on, orchiectomy, but it's not zero. And so, we treat patients just by the AUA guidelines, as you would any patient. But there has been some kind of buzz about lowering the PSA cutoff, because of the issues with hormones.

Sexual function is a talk in and of itself, and I would encourage you to go to, you can Google it, the WPATH guidelines, there's a great section on it. They talk about gender affirming hormone treatments, and when you start to see sexual side effects, and things like that, as well as patients pre and post bottom surgery. It's a great resource if you see a patient like this.

And finally, fertility, any in the urologic sphere, right? Patients who are assigned male at birth, AMAB, should really be offered fertility preservation before starting hormone therapy. But they can still bank if they've started hormones by coming off of those. Cryopreservation is an option, and they should know that.

So my major takeaways are that, have an awareness that TGD patients are going to seek care for basic urologic issues, and they don't all follow the same path. So ask them, and if you make a mistake, apologize, it's not a big deal. Move on. They'll appreciate that.

Utilize all the resources that are out there. WPATH, the AUA has great resources, the Core Curriculum, Updates.

Find champions to refer to in sexual health, pelvic floor physical therapy, people you know that are affirming. And if you don't think you can manage it, maybe it is best handled with a multidisciplinary approach. And there are programs that are sprouting up everywhere. So that's the good news.

These are some resources for you that are available in the PowerPoint.

And then, you can always email me, or our program director at the Gender Pathways are happy to help you out with resources. Thank you.

Outpatient Urethral Reconstruction LUGPA 2022 Presentation - Brad Figler

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Brad Figler presents on outpatient urethral reconstruction. Biography: Brad Figler, MD, FACS, Associate Professor (Urology/Plastic Surgery), University of North Carolina-Chapel Hill, Chapel Hill, NC Read the Full Video Transcript

Brad Figler: I'm going to be talking about urethral reconstruction for urethral strictures as an outpatient and in an ASC. I have no disclosures.

This is anatomy that I'm sure is familiar to everyone here. The fossa navicularis is in the distal penis, just proximal to the meatus. Bulbar urethra is in the scrotum and perineum. And the membranous urethra is just distal to the prostate.

In terms of things that we can do for urethra reconstruction and ASC before surgery, I think patient selection is key. Comorbidities like coronary artery disease, obesity, and sleep apnea, make outpatient ASC surgery a little more difficult. Anticoagulants may increase the risk of inter-op or post-op bleeding, so these patients may benefit from closer monitoring post-operatively.

For patients on chronic opioids, it may be difficult to control pain post-operatively, and therefore, these patients may need longer period of observation.

In terms of procedure selection, you'll want to consider duration of surgery, blood loss, physiologic burden of surgery, as well as post-operative pain control, and any other specialized post-operative care that the patient may need.

Communication with the patient and caregiver is really important. So we have detailed handouts for each surgery that we give to patients at the clinic visit when they book the surgery, so they know what to expect after surgery and can plan around that.

Finally, a thorough diagnostic workup will allow you to predict what's going to happen in the OR, and avoid a situation where the patient has a more invasive or more painful surgery than you anticipated.

Things to do to optimize the surgery itself include local and regional blocks to minimize pain postoperatively. Good communication with nursing and anesthesia is essential, and can allow for a quicker and less painful recovery, better discharge planning, and shorter PACU stay. Longer surgeries require more recovery, so it's important to have a plan and to communicate with everyone in the OR ahead of time, so they can anticipate needs. And finally, small things like minimizing blood loss often result in a quicker and more predictable recovery.

After surgery, communication with PACU staff is helpful, as our comprehensive and accurate discharge instructions. These patients have a lot of questions after surgery, so you'll want to plan for an uptick in phone calls and EMR, and probably reserve some capacity in your clinic for seeing post-op patients with questions or concerns.

I'm going to move on now to surgical technique. I'll try to get through everything without going over. Penile urethral strictures are caused by lichen sclerosis, BPH surgery, and STDs. Workup includes retrograde voiding and/or pull back urethrograms. The penile urethra is fixed to the corpus cavernosum and not very robust, so excisional procedures are typically not used on the penis. Instead, we utilize a lot of tissue transfer with either a graft or a flap. The patient shown here had a long eight French stricture in his penile urethra. So we performed a ventral onlay with a fasciocutaneous flap.

This patient had a very narrow fossa navicularis stricture that was about a centimeter in length. We perform these urethroplasties through the meatus, so the scar's excised and a buccal mucosal graft is parachuted in through the meatus.

For patients with really severe penile urethral strictures, typically due to lichen sclerosis or failed hypospadias repair, we perform a staged urethroplasty. In the first stage, we apply buccal mucosal graft to the disease segment, and create a urethrostomy proximal to the repair. In the second stage, we tubularize the reconstructed urethra. In the two photos on the right, you can see how the graft and adjacent tissue soften up over time. This makes the second surgery a lot more reliable.

All of these penile reconstructions are amenable to an outpatient or an ASC setting. They can be somewhat technical, but pain is minimal with appropriate penile blocks. The surgeries are not physically demanding, and the postoperative course is predictable.

So moving on now to bulbar urethra strictures caused by trauma, instrumentation/surgery, radiation. Workup includes retrograde and sometimes avoiding urethrogram. The bulbar urethra is robust and redundant, so short strictures can be excised in the remaining urethral and sutured to each other.

When possible, we try to preserve blood supply to the corpus spongiosum. In the picture on the left, you can see that we preserve the bulbar artery. At the bottom right, there's enough mobility on the adjacent urethra to do an excision and primary anastomosis, without dividing this artery. For longer strictures, some form of tissue transfer is necessary. In the photo on the right, we're performing a dorsal onlay by suturing the buccal mucosal graft to the corpus cavernosum and then to the spatulated urethra. So bulbar urethra reconstruction's also very minimal to outpatient in a ASC setting. Pain is minimal with appropriate blocks, and post-operative course is also predictable.

Posterior urethral strictures caused by treatments for prostate cancer, or BPH, or trauma. Workup includes retrograde and voiding urethrograms. The status of the continence mechanism in the bladder neck and membranous urethra are really important parts of the treatment algorithm. So we often do cystograms to assess bladder neck function, and integrate urethroscopy to determine whether these structures are involved in the disease process. Reconstructive options depend, in large part, on etiology, status of the continence mechanisms in location. So I'll run through a few common types of posterior urethroplasties that we perform as an outpatient.

For patients with a focal membranous urethral stricture and an intact bladder neck, an excisional urethroplasty is a great option. For patients with a non-functional bladder neck, a sphincter-sparing approach is really useful.

This is a video of a sphincter-sparing membranous urethroplasty. The video is made by Reynaldo Gomez in Chile, a reconstructive urologist who allowed me to share it here. But you can see that he's dissecting the sphincter off of the membranous urethra. So for patients who don't have a good internal sphincter, and rely on the external sphincter for continence, this allows for excision of the diseased membranous urethra with maintenance of continence.

Brachytherapy strictures tend to be limited to the prostatic apex and membranous urethra, as you can see in the voiding urethrogram images at the bottom. In this case, it's pretty straightforward to perform an excision in primary anastomosis.

So recently, we've been able to offer more reconstructive options to patients with post-prostatectomy and anastomotic strictures. Jonathan Warner from Mayo Clinic developed a sheath that fits a five millimeter suturing device in a digital ureteroscope. So we can now offer these patients trans urethral incision and re-approximation, or what he calls TUIMR.

For patients who aren't candidates for, or who are failed TUIMR, we're also able to offer more formal reconstruction, either robotically, or via a perineal pre-rectal approach.

Like many of the surgeries that I discussed, these are technically involved, but not physiologically demanding or very painful, so amenable to outpatient or ASC surgery.

Thanks.

Transgender Health and Bottom Surgery LUGPA 2022 Presentation - Brad Figler

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Dr Brad Figler presented on Transgender Health and Bottom Surgery. Biography: Brad Figler, MD, FACS, Associate Professor (Urology/Plastic Surgery), University of North Carolina-Chapel Hill, Chapel Hill, NC Read the Full Video Transcript Brad Figler: Thank you so much. This is a topic that's really near and dear to my heart, so I'm really grateful to be able to give this talk today and really grateful to LUGPA for putting this panel together, so thanks. All right, I have no disclosures.

Transgender issues have been all over the news recently. We hear about renewed efforts by state legislatures to ban gender-affirming care in limited bathroom access and acts of violence targeting transgender people. But there's also a lot of good news for transgender folks, including advances in and improved access to healthcare. My goal today is to provide an overview of gender-affirming care and bottom surgery so that regardless of your specialty or practice type, you can take great care of these patients when you do see them.

I'll start with a primer and what it means to be transgender, including some basic terminology and epidemiology. I'll then talk a little bit about what we at UNC have done to address challenges specific to this patient population and ensure that we're providing them with high quality care. I'll then go over bottom surgery in some detail so that you have a better understanding of who's having surgery, when they're having surgery, and what's being done. There's a lot of genital anatomy in this talk, so beware.

This is some basic terminology. Cis-gender is when gender identity is congruent with birth sex. Transgender is when gender identity is not congruent with birth sex. As you can see in the figure on the bottom right, a trans-female would be someone who is assigned male at birth but identifies as female, a trans-male would be someone who is assigned female at birth but identifies as male, and then gender non-conforming individuals don't identify as strictly male or female.

Gender dysphoria refers to the distressed caused by gender identity that doesn't match the sex assigned at birth. Gender-affirming surgery and hormones are an attempt to make the body consistent with the patient's gender identity. Top surgery generally refers to breast reduction for masculinizing patients and breast augmentation for feminizing patients, and then bottom surgery refers to vaginoplasty, or the creation of a vagina, for trans-female patients, and then metoidioplasty or phalloplasty in order to create a phallus for male patients.

There a lot of transgender patients in this country, according to a 2015 survey, there are approximately 1.4 million transgender people in this country, or 0.6% of the population. These patients use the healthcare system. 50% are on hormones and 25% have had gender-affirming surgery. These numbers probably changed since 2015, but we don't have more recent data.

There are many barriers to medical care for transgender patients. They are more likely to live in poverty, which makes it much harder to access our healthcare system. When they do have insurance, the rate of denials is high. In that survey, it was 55% for gender-affirming surgery and 25% for gender-affirming hormones. Insurance coverage for transgender care has improved significantly since 2015, but continues to be a barrier. Many transgender patients have had a negative experience with a healthcare professional and avoid medical care for fear of being mistreated. And finally, there's just not enough qualified healthcare professionals. So these patients are here, they need medical care, and there are a lot of barriers to accessing medical care.

Recognizing that this is a vulnerable population with unique medical and social needs, we started the UNC Transgender Health Program in 2019. Our mission is to improve access to UNC Health for transgender patients in the region, support growth of transgender services at UNC, and to support coordination and quality of care for transgender services at UNC.

Operationally, we focus on access, coordination and education. We attempt to work with all the great people across our healthcare system who are interacting with or impacting our patients in order to improve the experience, outcomes, and efficiency. We have an incredible team and we're growing. Among other things, our team helps ensure that the first person our patients interact with when they reach out to UNC is gender-affirming and knowledgeable. Taking together, I believe the Transgender Program levels the playing field, so that despite some unique medical and social needs, our patients are able to navigate our healthcare system and get the care that they need.

I'll kind of switch gears now and talk about bottom surgery. The world Professional Association for Transgender Health, or WPATH, recommends these prerequisites for surgery. It's worth noting that patients must have been living in their preferred gender role for 12 months before undergoing bottom surgery. That's important because surgery really is the final step in for these patients, not something that happens early on in the transition. Other preoperative considerations include smoking and nicotine cessation, control of blood sugars, social support, fertility preservation if desired, and hair removal. These are figures that we give our patients so they can coordinate with their hair removal technicians.

Vulvoplasty is the creation of external female genitals, typically includes orchiectomy, creation of labia minora from the penile skin, creation of labia majora from the scrotal skin, creation of a clitoris, from the glans penis and erectile tissue, and creation of a perineal urethrostomy. Vaginoplasty is a vulvoplasty plus the creation of a vaginal canal. Our goal for these surgeries is to create natural-appearing female genitals that require minimal maintenance, allow for an unobstructed urine stream, erogenous sensation, and in the case of a vaginoplasty, receptive penetrative intercourse. I'll start with a video of a vaginoplasty just to give you some context and then I'll discuss the various steps in more detail after you've seen the video.

Video: Skin is incised sharply. Scrotal skin is removed and will later be used as a full thickness skin graft. Orchiectomy is performed with generous cord block. Dartos fascia divided in the midline. Corpus spongiosum is mobilized. Denonvilliers' fascia is incised, allowing the prostate and the rectum to be separated. Space for the vaginal canal is created with blunt dilation. The Bulbospongiosus muscle is resected.

The urethra is mobilized off the erectile bodies and divided distally. The remaining urethra is spatulated and resected. A dorsally-based W-shaped segment of the glans penis is used to form the glans clitoris. Penile skin flaps are developed. Bipolar electrocautery is used to preserve the microvasculature of the flap. Distal penile skin forms the dorsal hood. Ventral tunica albuginea is resected. Corpora cavernosa are folded and tunica albuginea is closed. The folded tunica albuginea is secured to pubic periosteum and covered by Scarpa's fascia. The distal urethra is resected.

Approximately, the urethra is secured to the clitoris and then spatulated ventrally. Corpus spongiosum is closed and secured to the clitoral hood. Excess corpus spongiosum is excised and the defect is closed. Posterior perineal flap is secured to the perineal body. Penile skin flaps are advanced to the posterior perineum. The clitoral hood is completed. Vestibular and urethra meatus are secured to adjacent skin. Skin edges are approximated. The skin graft is placed in the vaginal canal, then trimmed and secured to the introitus. Incisions are closed with absorbable suture. A foam bolster is placed in the vaginal canal and covered with cotton gauze, which is secured with absorbable suture.

Brad Figler: Okay. Post-operatively, patients are discharged on day 1 or 2. We encourage early and frequent ambulation. There's no bedrest. Bolster dressing and catheter are removed on post-operative day 6. We begin dilation 2 to 4 weeks and then follow patients closely for 1 year after surgery.

I'll switch gears again now and talk about masculinizing bottom surgery, metoidioplasty and phalloplasty. Masculinizing bottom surgery is often confusing and I think it's because there's so many options. Generally speaking, patients need to decide if they want a phalloplasty, which is a larger penis and a more invasive surgery, or metoidioplasty, which is a smaller penis and a less invasive surgery. Another big decision is whether they want urethra lengthening, which is where the urethra is extended from the native meatus to the tip of the phallus so they can stand to void. So the choice of surgery depends on the patient's goals, patient-specific factors like obesity, diabetes, or vascular disease, and their risk tolerance. Once again, before discussing too many details, I'll show you a video just to give you a general sense of what happens during masculinizing bottom surgery. This is a metoidioplasty.

Video: We begin with the U-shaped incision in the labia minora, which will become the urethra. Vaginal epithelium is cauterized and the canal is closed. The labia minora is mobilized so they can be moved anteriorly and tubularized. Labia minora are approximated dorsally, then ventrally. Adjacent tissue is closed over the urethra to prevent fistulas. Penile skin and urethra closures are completed. Labia majora are mobilized inferiorly and laterally. The perineum is closed. Labia majora rotated 180 degrees to create a pouch-like scrotum in the anterior peritoneum.

Brad Figler: Okay. I like to think of masculinizing bottom surgery as a puzzle. There are six puzzle pieces and you can assemble the puzzle pieces in any number of ways. The pieces are the penis, the glans penis, scrotum, penile urethra, pars fixa, which is the region between the native urethra and the penile urethra in the vaginectomy. I'll describe each puzzle piece in detail and then talk about different ways of putting the puzzle piece together.

There many ways of creating the penis. The most common are the radial forearm free flap, anterolateral thigh flap, or ALT in metoidioplasty, which is the video that you just watched In terms of phalloplasty, the radial forearm free flap is by far the most common approach because it's reliable and results in physiologic length and girth. For the scrotoplasty, we utilize what we call Ghent scrotoplasty after the group in Ghent, Belgium that described it. The scrotum is constructed from anteriorly-based labia majora flaps that are rotated 180 degrees to form a pouch-like scrotum in the anterior perineum. Vaginectomy is performed by excising or fulgurating the vaginal epithelium and then performing a colpocleisis.

The most common approach to glansplasty is a Norfolk technique after the surgeons at EVMS who described it. The skin and the distal penis is advanced 1 centimeter distally, the edge of the flap is sutured to the base, and then the defect is covered with a full thickness skin graft. For a radial forearm free flap, the urethra is typically created with a tube within a tube technique in which one part of the flap is rolled into a tube for the urethra, and the rest of the tube is wrapped around the first tube to form the phallus. In a metoidioplasty, the distal clitoral skin is tubular to form the penile urethra.

In a phalloplasty, the pars fixa, or bulbar urethra, is usually formed from simple tubularization of a labia minora. In a metoidioplasty, the pars fixa is formed either from a combination of a buccal graft in a labia minora flap, or from bilateral anteriorly-based labia minora flaps.

Once you have the puzzle pieces, you have a choice about how you want to put those pieces together. As a single stage staged with the phalloplasty first or staged with metoidioplasty first. At UNC, our preference is for phalloplasty first, though we do perform metoidioplasty first, particularly when the patient feels they may reach their goal after metoidioplasty and not move on to phalloplasty. Thanks again for the opportunity to speak.

Systemic Treatment Options for MIBC and NMIBC - Arlene Siefker-Radtke

Details
Arlene Siefker-Radtke discusses the perioperative management of urothelial cancer, focusing on the balance between efficacy and toxicity in treatments. She reflects on the standard use of cisplatin-based chemotherapy, its associated long-term side effects, and how nearly half of urothelial cancer patients find this treatment intolerable. Dr. Siefker-Radtke touches on the ongoing debate between Dos...

Urologic Care for the LGBT Community LUGPA 2022 Presentation - Channa Amarasekera

Details
At the 2022 Large Urology Group Practice Association (LUGPA) annual meeting, Channa Amarasekera presented on urologic care for the LGBT community during Appreciating Diversity in Urology Care. Biography: Channa Amarasekera, MD, Assistant Professor, Director, Gay and Bisexual Men’s Urology Programs, Northwestern University, Feinberg School of Medicine, Chicago, IL Read the Full Video Transcript {ar...

Evaluating the Efficacy and Advantages of Prostate Artery Embolization in BPH Treatment - Sandeep Bagla

Details
Sandeep Bagla delves into the importance and practicality of Prostate Artery Embolization (PAE) in the treatment of Benign Prostatic Hyperplasia (BPH). He further underlines the necessity for minimally invasive treatments as a significant number of men reject urologist-recommended treatments. Bagla elaborates on the PAE procedure, involving the delivery of microscopic spheres into the prostatic ar...